CD40LG and Lyme disease: The performance of the SERA Lyme IgG and IgM panels was assessed using an independent validation set of 454 specimens positive for antibodies to B. burgdorferi by STTT (Lyme disease validation cohort) and >1,000 repertoires obtained from individuals with unknown Lyme serostatus (control validation cohort) (Table 1).